Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8215806 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 42 Pages |
Abstract
In the largest reported analysis of WPRT for patients with high-risk prostate cancer treated in the dose-escalated era, the addition of WPRT demonstrated no survival advantage compared with PO-RT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Arya MD, Bernard L. PhD, Norman MD, PhD, Chad G. MD, Hirotatsu PhD, Brian D. MD, MPH,